The contribution of radioimmunoassay to the study of interferon's pharmacokinetics in patients with neoplasmas
Abstract
The use of interferon alpha is currently established for the treatment of certain neoplastic diseases and among them for the management of malignant melanoma. Considering the extremely high cost of this product and the existing relationship between the therapeutical results and the levels of the drug in the serum, the individualization of dose becomes a necessity. The pharmacokinetics of interferon alpha was studied in ten consecutive patients suffering from malignant melanoma who were hospitalized at the First Chemotherapy Clinic of "Theagenion" Cancer Institute. Two methods for identifying the levels of the substance in the serum were used: The inhibition of the enzyme 2’5 oligo (A) synthetase and the radioimmunoassay (RIA). The aim of this study was to check if the RIA, due to its simplicity and rapidness can be used as a routine substituting the well known and widely used for year’s enzymatic method. All the patients were included for the first time in an interferon protocol with 5 ...
show more
Download full text in PDF format (3.68 MB)
(Available only to registered users)
|
All items in National Archive of Phd theses are protected by copyright.
|
Usage statistics
VIEWS
Concern the unique Ph.D. Thesis' views for the period 07/2018 - 07/2023.
Source: Google Analytics.
Source: Google Analytics.
ONLINE READER
Concern the online reader's opening for the period 07/2018 - 07/2023.
Source: Google Analytics.
Source: Google Analytics.
DOWNLOADS
Concern all downloads of this Ph.D. Thesis' digital file.
Source: National Archive of Ph.D. Theses.
Source: National Archive of Ph.D. Theses.
USERS
Concern all registered users of National Archive of Ph.D. Theses who have interacted with this Ph.D. Thesis. Mostly, it concerns downloads.
Source: National Archive of Ph.D. Theses.
Source: National Archive of Ph.D. Theses.